Alcon (ALC) Capital Expenditures (2009 - 2026)
Alcon (ALC) posted quarterly Capital Expenditures of -$139.0 million for Q1 2026, up 17.75% on a QoQ basis from -$169.0 million in Q4 2025.
Alcon (ALC) Capital Expenditures (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Capital Expenditures for 11 consecutive years, with -$139.0 million the latest figure, recorded in Q1 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to -$139.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$576.0 million (changed N/A YoY) and the FY2025 annual result came in at -$543.0 million, down 14.8% from the prior year.
- Capital Expenditures climbed to -$139.0 million in Q1 2026 per ALC's latest filing, from -$169.0 million in the prior quarter.
- Over the last five years, Capital Expenditures for ALC reached as high as $1.0 billion in Q4 2022 and fell as low as -$169.0 million in Q4 2025.
- A 5-year average of $15.3 million and a median of -$118.0 million in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures increased 22.5% — and 2024, when it sank 115.05%.
- Year by year, Capital Expenditures stood at $1.0 billion in 2022, then fell by 2.9% to $1.0 billion in 2023, then slumped by 115.05% to -$151.0 million in 2024, then dropped by 11.92% to -$169.0 million in 2025, then gained by 17.75% to -$139.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$139.0 million, -$169.0 million, and -$166.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 137.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -139.00 Mn |
| Mar 31, 2026 | -139.00 Mn |
| Dec 31, 2025 | -169.00 Mn |
| Dec 31, 2025 | -169.00 Mn |
| Sep 30, 2025 | -166.00 Mn |
| Sep 30, 2025 | -166.00 Mn |
| Jun 30, 2025 | -102.00 Mn |
| Jun 30, 2025 | -102.00 Mn |
| Dec 31, 2024 | -151.00 Mn |
| Dec 31, 2024 | -151.00 Mn |
| Sep 30, 2024 | -118.00 Mn |
| Sep 30, 2024 | -118.00 Mn |
| Jun 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | -92.00 Mn |
| Mar 31, 2024 | -112.00 Mn |
| Mar 31, 2024 | -112.00 Mn |
| Dec 31, 2023 | 1.00 Bn |
| Dec 31, 2023 | 1.00 Bn |
| Sep 30, 2023 | -124.00 Mn |
| Sep 30, 2023 | -124.00 Mn |